+++ Einfach investieren ? mit Kapitalschutz oder Teilschutz ? raiffeisenzertifikate.at ? jetzt in Zeichnung +++ -W-
27.09.2013 14:00:00

Exclusive Endorsements, Clinical Affiliations, Integration Agreements, Quarterly Dividends and Awareness Programs - Research Report on Walgreens, CVS Caremark, McKesson, Omnicare, and GNC

NEW YORK, September 27, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Walgreen Company (NYSE: WAG), CVS Caremark Corporation (NYSE: CVS), McKesson Corporation (NYSE: MCK), Omnicare, Inc. (NYSE: OCR), and GNC Holdings, Inc. (NYSE: GNC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Walgreen Company Research Report

On September 16, 2013, Walgreen Company (Walgreens) reported that the American Hospital Association (AHA) has exclusively endorsed Walgreens WellTransitions, recognizing the program for its medication adherence. According to the Company, the innovative, coordinated care program aimed at improving medication adherence has demonstrated reductions in hospital readmission rates by helping patients better understand prescription therapies during and after discharge. "Through WellTransitions, Walgreens pharmacy staff works closely with the hospital team to improve the transition of patients to their homes by educating and encouraging them to take their medications as prescribed," said Joel Wright, Group Vice President of Enterprise Specialty at Walgreens. "Medication non-adherence is a significant contributor to preventable readmissions, and by providing this level of personalized care, we can play an important role in helping more people get, stay and live well." The Full Research Report on Walgreen Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/844c_WAG]

--

CVS Caremark Corporation Research Report

On September 19, 2013, CVS Caremark Corporation (CVS Caremark) announced that its retail health care division, MinuteClinic, and health care network in northwest Florida, Baptist Health Care (Baptist) has entered into a clinical affiliation to enhance access to health care services in Escambia, Okaloosa, and Santa Rosa counties. Pursuant to the agreement, Baptist physicians will serve as medical directors for four MinuteClinic walk-in medical clinics inside select CVS/pharmacy stores in Cantonment, Crestview, Gulf Breeze, and Niceville, as well as future locations in the region. Further, MinuteClinic and Baptist will collaborate on patient education and disease management initiatives. The Full Research Report on CVS Caremark Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/f53e_CVS]

--

McKesson Corporation Research Report

On September 24, 2013, McKesson Corporation (McKesson) announced that its division, McKesson Specialty Health, together with the National Comprehensive Cancer Network (NCCN) and the US Oncology Network, has entered into agreements to provide future integration with Elekta and Varian that is expected to enhance the ability to provide cancer patients with evidence-based quality care. The Companies informed that by integrating with two leading oncology information systems-Elekta's MOSAIQ and Varian's ARIA, the power of Clear Value Plus will be improved for practices using those platforms. Also, the Companies believe that the agreements to integrate the Elekta and Varian oncology information systems with the Clear Value Plus platform in an open, standards-based integration of technology will provide physicians with access to quality support and reporting solutions, as well as Value Pathways treatment options. Further, NCCN's Value Pathways, which are incorporated into Clear Value Plus, will expand to include radiation oncology in 2014. The Full Research Report on McKesson Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/a057_MCK]

--

Omnicare, Inc. Research Report

On September 12, 2013, Omnicare, Inc.'s (Omnicare) Board of Directors has approved a quarterly cash dividend of $0.14 per share on the Company's common stock. Omnicare informed that the dividend is payable on September 27, 2013, to stockholders of record as of September 23, 2013. The Full Research Report on Omnicare, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/ef9e_OCR]

--

GNC Holdings, Inc. Research Report

On September 23, 2013, GNC Holdings, Inc. (GNC) announced that it is partnering with 57 of its third party vendors, in support of the National Breast Cancer Foundation (NBCF) during the National Breast Cancer Awareness Month in October 2013. The Company informed that its customers will be invited to join in support of this important cause starting October 1, 2013, by making $1, $5, and $10 donations at any of GNC's US retail corporate and franchise locations, as well as online at the Company's website. Janelle Hail, Founder and CEO of NBCF said, "Through their partnership with NBCF, they will also be helping us save lives. Early detection of breast cancer is critical to survival, but so many women in America don't have access to the resources they need to detect it early. GNC's generous donation will help us provide free mammograms and patient navigation services for underserved woman in all 50 states."  The Full Research Report on GNC Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/54b0_GNC]

----

EDITOR NOTES:

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

    CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

    AnalystsCorner.com

    SOURCE Analysts' Corner

    Nachrichten zu Walgreen Co.mehr Nachrichten

    Keine Nachrichten verfügbar.

    Analysen zu Walgreen Co.mehr Analysen

    Eintrag hinzufügen
    Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
    Es ist ein Fehler aufgetreten!

    Aktien in diesem Artikel

    CVS Health Corp 55,53 0,85% CVS Health Corp
    McKesson Corp. 597,00 0,03% McKesson Corp.